Phone
Address
ZhengZhou (HQ), Shenzhen (R&D Center), Suzhou (R&D Center), China
Clinic Signification:
In 2008, WHO separated “Myeloid/lymphoid neoplasms with eosinophilia associated with rearrangements of PDGFRA, PDGFRB, or FGFR1” into a new category. Even if the three abnormal target groups are not accompanied by BCR/ABL fusion genes, they are sensitive to imatinib treatment.
FGFR1 Normal
FGFR1 Breakapart
Probe Description: FGFR1
Cat.No.: CF1245
Specification: 10 tests/box, 20 tests/box